Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coping with stress: multiple ways to activate p53.

H F Horn1, K H Vousden

  • 1The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Glasgow, UK.

Oncogene
|February 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

p53- and p73-independent activation of TIGAR expression in vivo.

Cell death & disease·2015
Same author

Functional interplay between MDM2, p63/p73 and mutant p53.

Oncogene·2014
Same author

Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo.

Cell death and differentiation·2014
Same author

Suppression of acetate mutants in Coprinus : I. Identification of two isoaccepting tRNA suppressors of a missense mutation.

Current genetics·2013
Same author

Suppression of acetate mutants in Coprinus : II. Correlation of recessiveness and dosage effects with suppressed enzyme level.

Current genetics·2013
Same author

Functions of TAp63 and p53 in restraining the development of metastatic cancer.

Oncogene·2013
Same journal

Correction: SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.

Oncogene·2026
Same journal

Correction: Liver-specific SIRT1 knockout-induced hyperglycemia promotes spontaneous lung adenocarcinomas through HSF1-MDM2.

Oncogene·2026
Same journal

Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.

Oncogene·2026
Same journal

Matrix stiffness drives HCC invasion and metastasis via interfering with TRIM21-mediated SCD1 ubiquitination.

Oncogene·2026
Same journal

DNA methylation-mediated silencing of STAT5A drives breast cancer metastasis via dual regulation of EMT and immunosuppressive microenvironment.

Oncogene·2026
Same journal

LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling.

Oncogene·2026
See all related articles

The tumor suppressor protein p53 (also known as TP53) is activated by diverse stress signals through various pathways. Understanding these mechanisms is key to developing targeted cancer therapies.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cellular Stress Response

Background:

  • The p53 protein is a critical regulator of cellular responses to stress.
  • It plays a central role in preventing tumor development by responding to oncogenic insults.
  • The complexity of p53's regulatory network and effector pathways is increasingly recognized.

Purpose of the Study:

  • To review recently identified roles of p53 in tumor suppression.
  • To discuss the diverse mechanisms regulating and activating p53.
  • To highlight the importance of understanding p53 pathways for therapeutic target identification.

Main Methods:

  • Literature review of recent studies on p53.
  • Analysis of signaling pathways involved in p53 activation.

Related Experiment Videos

  • Examination of p53's role in different stress responses and tumor suppression.

    • Main Results:

    • p53 is activated by a wide array of stress signals through distinct pathways.
    • Different stress stimuli can elicit specific p53-mediated responses.
    • The contribution of these responses to inhibiting malignant progression is being elucidated.

    Conclusions:

    • Clarifying p53's tumor suppressive functions and regulatory mechanisms is crucial.
    • Identifying key p53 responses in tumor suppression can guide the development of novel cancer therapeutics.
    • Further research into p53 regulation and activation holds promise for effective cancer treatment strategies.